The Chinese Academy of Medical Sciences "Transfusion Adverse Reaction Mechanism and Intervention" project was approved（2016-12M-3-024）

Lead unit: Institute of Blood Transfusion, Chinese Academy of Medical Sciences
Participants: Background Concord Hospital of Chinese Academy of Medical Sciences, Fuwai Hospital of Chinese Academy of Medical Sciences, Cancer Hospital of Chinese Academy of Medical Sciences

“"Transfusion adverse reaction mechanism and intervention" project officially launched

The main research direction of the project is the safety of blood transfusion, with the aim of reducing the adverse reactions of blood transfusion, starting from improving blood safety and reducing irrational blood use, focusing on the main factors affecting the safety and effectiveness of blood transfusion, carrying out basic, clinical and applied research to improve the efficacy of blood transfusion. Reduce medical costs and provide scientific support for the establishment of a national early warning system for adverse blood transfusion reactions.

Discuss the establishment of the "Adverse Blood Reaction Research Alliance"

The “Transfusion Adverse Reaction Research Alliance” was initiated and established by the innovation team of “Influencing Mechanism and Intervention of Adverse Blood Reaction” in the Medical and Health Science and Technology Innovation Project of the Chinese Academy of Medical Sciences. The platform, combined with the clinical and scientific research teams in the industry, carries out clinical and scientific research collaboration, resource sharing, academic exchanges and talent training。

Chinese Academy of Medical Sciences "Research on the Mechanism and Intervention of Adverse Blood Transfusion Reactions" Project Research Convened

In order to further expand the influence of the Medical and Health Technology Innovation Project of the Chinese Academy of Medical Sciences, promote research results, and expand the verification and research scope of results. The Alliance for Research on the Adverse Reaction of Blood Transfusion led by the Innovation Team of the Adverse Reaction Mechanism and Intervention of the Transfusion Adverse Reaction Project of the Chinese Academy of Medical Sciences and Medical Science and Technology Innovation Project was successfully held in Hefei, Anhui Province on March 18-20, 2018 。

The transfusion adverse reaction reporting system is officially launched

In order to further expand the influence of the Medical and Health Technology Innovation Project of the Chinese Academy of Medical Sciences, promote research results, and expand the verification and research scope of results. Establish a unified data collection platform to provide real and effective data samples for the innovation team of the Medical and Health Technology Innovation Project of the Chinese Academy of Medical Sciences, "Transfusion Adverse Reaction Mechanism and Intervention。

The 1st Early Warning Conference on Adverse Reactions in Blood Transfusion Held Successfully

In order to further promote the influence of the Transfusion Adverse Reaction Research Alliance, standardize the diagnosis and reporting process of transfusion adverse reactions, strengthen the medical staff's awareness of adverse transfusion reactions, and promote the establishment of a national early warning system for transfusion adverse reactions. The 1st Blood Transfusion Adverse Reaction Warning Conference was successfully held in Beijing, the capital of July 24-27, 2018。

Jilin Provincial Branch Alliance, Yunnan Provincial Branch Alliance was established

In order to further promote the influence of the Alliance for the Study of Adverse Reactions in Blood Transfusion and the establishment of a national early warning system for adverse reactions in blood transfusions. In October 2018, the Alliance for Transfusion Adverse Reaction Research-Jilin Provincial Sub-Union and the Alliance for Transfusion Adverse Reaction Research-Yunnan Provincial Sub-Union。

“Official website of  Blood Warning Alliance

In order to further promote the influence of the Alliance for the Study of Adverse Reactions in Blood Transfusion and the establishment of a national early warning system for adverse reactions in blood transfusions. On November 5, 2018, the official website of China Blood Warning Alliance was launched, introducing our members, recording our history, showing our work, and at the same time integrating and optimizing the system for reporting transfusion adverse reactions。

 Blood warning alliance English official website online

In order to further promote the influence of the Transfusion Adverse Reaction Research Alliance, the Chinese Blood Warning Alliance English official website was launched on December 25, 2018. We hope that our research on the occurrence and early warning mechanism of transfusion adverse reactions can improve the safety of blood transfusion patients worldwide Play a role in promoting。

“The mid-term self-assessment meeting of the innovative engineering project "Research on the Mechanism of Adverse Blood Reaction" was held in Beijing

On May 26, 2019, the mid-term self-assessment meeting of the Collaborative Innovation Team Project "The Mechanism and Intervention of Adverse Reactions in Transfusion" of the Chinese Academy of Medical Sciences Medical and Health Technology Innovation Project was successfully held in the Academic Hall of Peking Union Medical College。